Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials
- Author
- Johan Vande Walle (UGent) , J Delmas, G Ardissimo, J Wang, J Kincaid and H Haller
- Organization
Downloads
-
8603307.pdf
- full text
- |
- open access
- |
- |
- 328.68 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8603308
- MLA
- Vande Walle, Johan, et al. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-Term Outcomes : A Pooled Analysis of Clinical Trials.” CRITICAL CARE, vol. 19, no. suppl. 1, 2015, pp. S116–17, doi:10.1186/cc14410.
- APA
- Vande Walle, J., Delmas, J., Ardissimo, G., Wang, J., Kincaid, J., & Haller, H. (2015). Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials. CRITICAL CARE, 19(suppl. 1), S116–S117. https://doi.org/10.1186/cc14410
- Chicago author-date
- Vande Walle, Johan, J Delmas, G Ardissimo, J Wang, J Kincaid, and H Haller. 2015. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-Term Outcomes : A Pooled Analysis of Clinical Trials.” In CRITICAL CARE, 19:S116–17. https://doi.org/10.1186/cc14410.
- Chicago author-date (all authors)
- Vande Walle, Johan, J Delmas, G Ardissimo, J Wang, J Kincaid, and H Haller. 2015. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-Term Outcomes : A Pooled Analysis of Clinical Trials.” In CRITICAL CARE, 19:S116–S117. doi:10.1186/cc14410.
- Vancouver
- 1.Vande Walle J, Delmas J, Ardissimo G, Wang J, Kincaid J, Haller H. Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials. In: CRITICAL CARE. 2015. p. S116–7.
- IEEE
- [1]J. Vande Walle, J. Delmas, G. Ardissimo, J. Wang, J. Kincaid, and H. Haller, “Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials,” in CRITICAL CARE, Brussels, Belgium, 2015, vol. 19, no. suppl. 1, pp. S116–S117.
@inproceedings{8603308,
articleno = {{P330}},
author = {{Vande Walle, Johan and Delmas, J and Ardissimo, G and Wang, J and Kincaid, J and Haller, H}},
booktitle = {{CRITICAL CARE}},
issn = {{1466-609X}},
language = {{eng}},
location = {{Brussels, Belgium}},
number = {{suppl. 1}},
pages = {{P330:S116--P330:S117}},
title = {{Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials}},
url = {{http://dx.doi.org/10.1186/cc14410}},
volume = {{19}},
year = {{2015}},
}
- Altmetric
- View in Altmetric